Latour Wouter 4
4 · Vaxart, Inc. · Filed May 10, 2021
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Latour Wouter
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2021-05-06$1.70/sh+100,000$170,000→ 100,000 total - Exercise/Conversion
Common Stock
2021-05-07$1.70/sh+100,000$170,000→ 100,000 total - Sale
Common Stock
2021-05-06$6.54/sh−100,000$653,890→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-05-06−100,000→ 800,000 totalExercise: $1.70Exp: 2030-03-23→ Common stock (100,000 underlying) - Sale
Common Stock
2021-05-07$7.13/sh−100,000$712,750→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-05-07−100,000→ 700,000 totalExercise: $1.70Exp: 2030-03-23→ Common stock (100,000 underlying)
Footnotes (1)
- [F1]31.25% of the shares subject to this stock option vested on June 8, 2020, the grant date, with the remaining 68.75% vesting in 22 equal monthly installments on the first day of each calendar month thereafter, such that the option shall be fully vested on April 1, 2022.